About Cejemly® (Sugemalimab) The anti-PD-L1 monoclonal antibody sugemalimab was discovered by CStone using the OmniRat® transgenic animal…
About Pomalidomide Pomalidomide is an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related…
About Tazemetostat Tazemetostat is a selective inhibitor of EZH2, administered orally.It is approved treatment for Follicular…
About Pomalidomide Pomalidomide is an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related…
About Adagrasib Adagrasib is a prescription medicine used in adults: alone to treat non-small cell lung…
About Glumetinib or Gumarontinib Glumetinib (SCC244) also named Gumarontinib, is a highly selective, orally bioavailable, ATP-competitive c-Met…
About Pralsetinib Pralsetinib is a tyrosine kinase inhibitor. It is taken by mouth. Pralsetinib is a medication approved for RET mutation-positive medullary…
Abemaciclib is used in combination with an aromatase inhibitor such as anastrozole (Arimidex), exemestane (Aromasin), or…
Selumetinib is a prescription medicine that is used to treat children 2 years of age and…
Melanoma Indicated in combination with encorafenib for patients with unresectable or metastatic melanoma with a BRAF…
Tucatinib is an anticancer medication used for the treatment of HER2-positive breast cancer. It is a…
HANQUYOU® (Trastuzumab) sold under the brand name 汉曲优® in china, Since its launch, 汉曲优® has been…
Larotrectinib Larotrectinib is a medication for the treatment of cancer.It is an inhibitor of tropomyosin kinase receptors TrkA, TrkB, and TrkC. …
Larotrectinib Larotrectinib is a medication for the treatment of cancer.It is an inhibitor of tropomyosin kinase receptors TrkA, TrkB, and TrkC. …
Baricitinib is an orally bioavailable inhibitor of Janus kinases 1 and 2 (JAK1/2), with potential anti-inflammatory,…
Baricitinib is an orally bioavailable inhibitor of Janus kinases 1 and 2 (JAK1/2), with potential anti-inflammatory,…